Big pharma deals

CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

Derived from Current Agreements, our editors have selected notable big pharma deals from the life sciences in recent weeks – our Featured deals. Subscribe to our weekly newsletter to be updated on new featured deals and much more.

For comprehensive access to all life science deals as they are announced:

Deal Monitor - part of Current Partnering Insight, Deal Monitor allows you to track recent deals by industry sector, therapy area, technology type and stage of development - access now

Current Agreements - search over 40,000 deals to find benchmarks, monitor target company deal structures, identify companies active in your area(s) of interest, and much more - access now

Featured big pharma deals

All big pharma deals: Deal Monitor | Current Agreements

Pfizer creates breaking news with Allergan purchase

November 23, 2015 : Allergan, big pharma, merger, Pfizer

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. more »

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015 : big biotech, big pharma, biotech, partnering, pharma

An interview with Richard Brudnick, Senior VP, Corporate Development, Biogen

De-risking has evolved from literature searches to the cultivation of many wide-ranging relationships throughout the life sciences strata, according to Richard Brudnick, Senior VP, Corporate Development at Biogen. In a recent interview, Brudnick outlined key strategies to accessing innovation and “de-risking” risk through collaboration. more »

Boehringer Ingelheim acquires Pharmaxis’ anti-inflammatory candidate

May 18, 2015 : Boehringer Ingelheim, Pharmaxis

Boehringer Ingelheim exercises option and acquires global ownership of Pharmaxis’ investigational anti-inflammatory drug candidate PXS4728A, including associated intellectual property rights. more »

Endo International acquires Par Pharmaceutical

May 18, 2015 : acquisition, Endo, par

Endo International and Par Pharmaceutical Holdings have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion, including assumption of Par debt. more »

Transition Therapeutics licenses drug candidate from Eli Lilly

May 6, 2015 : Eli Lilly, Transition

Transition Therapeutics announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate (“TT701”) from Eli Lilly and Company. more »

EMD Serono and Pfizer in co-promotion agreement for Xalkori

May 6, 2015 : EMD Serono, Pfizer

EMD Serono has begun co-promoting Pfizer’s anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer. more »

Pfizer in collaboration agreement for lupus study

May 5, 2015 : 23andMe, Pfizer

23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer. more »

Bayer and Isis in ISIS-FXIRx licensing pact

May 5, 2015 : Bayer, big pharma, partnering

Bayer HealthCare has entered into an exclusive license agreement with Isis Pharmaceuticals on ISIS-FXIRx more »

Roche and 4D Molecular partner for AAV vectors

April 30, 2015 : big pharma, partnering, Roche

4D Molecular Therapeutics announced a collaboration and license agreement with Roche to discover and develop optimized next-generation AAV vectors more »

Celgene acquires Quanticel Pharmaceuticals

April 28, 2015 : big biotech, big pharma, Celgene, M&A

Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel more »

« Page 1, 2, 3 ... 124, »

Derived from Current Agreements, more featured partnering deals by category:

Big biotech

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Morphosys acquires Lanthio Pharma

May 7, 2015

Alexion to buy Synageva Biopharma

May 5, 2015

View more featured deals | all deals at Deal Monitor

Pharma

Pfizer creates breaking news with Allergan purchase

November 23, 2015

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Pfizer in asset purchase and option to acquire AM-Pharma

May 12, 2015

View more featured deals | all deals at Deal Monitor

Biotech

When de-risking, relationships matter: How using key strategies can get you to your next innovative partnership

August 10, 2015

Veracyte banks $40 million private placement

April 28, 2015

MedImmune and Immunocore partner for melanoma combinations

April 20, 2015

View more featured deals | all deals at Deal Monitor

Diagnostics

Ventana and Astellas in automated tissue diagnostics pact

April 15, 2015

Roche acquires Signature Diagnostics for access to translational oncology and genomics

February 12, 2015

Personalis gains $33 million series C

January 14, 2015

View more featured deals | all deals at Deal Monitor

Medical device

Abbott to distribute Sekiui’s coagulation testing solutions

April 15, 2015

Mallinckrodt acquires Ikaria for $2.3bn

March 5, 2015

Intuitive Surgical wins $430m surgical robotic systems contract

March 5, 2015

View more featured deals | all deals at Deal Monitor

Drug delivery

Janssen and Ichor Medical enter hep B vaccine delivery alliance

April 14, 2015

Sanofi Pasteur and VBI Vaccines in formulation pact

April 9, 2015

Sanofi and Vect-Horus collaborate to transport therapeutic antibodies into brain

January 20, 2015

View more featured deals | all deals at Deal Monitor

Print Friendly, PDF & Email